15 Feb 2021
According to results from a phase 3a STEP 1 trial published in the New England Journal of Medicine, a new weight loss drug called semaglutide shows encouraging results for treating obesity, but further research is needed.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024